Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.11, $0.13 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $182.2 million versus the consensus estimate of $169 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.